Investigations
Molecular Partners AG
Molecular Partners AG (MOLN) Misled Investors Regarding The Commercial Prospects of its Drug Candidates.
July 22, 2022
Investigations
Search
Categories
Archives
Investment Monitoring From Robbins LLP
To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.
Investigations
Outset Medical, Inc.
Outset Medical, Inc. (OM) Misled Investors Regarding Tablo’s Use and FDA Approval.
July 22, 2022
Investigations
TG Therapeutics, Inc.
TG Therapeutics, Inc. (TGTX) Overstated the Clinical and Commercial Prospects of its New Drugs.
July 20, 2022
Investigations
Inotiv, Inc.
Inotiv, Inc. (NOTV) Failed to Disclose that it Engaged in Widespread and Flagrant Violations of the Animal Welfare Act.
July 15, 2022
Investigations
Unity Software Inc.
Unity Software Inc. (U) Reduces Fiscal 2022 Guidance to the Detriment of Investors.
July 15, 2022
Investigations
Molecular Partners AG
Molecular Partners AG (MOLN) Misled Investors Regarding The Commercial Prospects of its Drug Candidates A shareholder filed a class action on behalf of all persons who purchased or otherwise acquired
July 14, 2022
Investigations
Missfresh Limited
Missfresh Limited (MF) Provided False Financial Figures in its Registration Statement in Support of its IPO A shareholder filed a class action on behalf of all persons who purchased
July 12, 2022
Investigations
Outset Medical, Inc.
Outset Medical, Inc. (OM) Misled Investors Regarding Tablo’s Use and FDA Approval A shareholder filed a class action on behalf of investors who purchased Outset Medical, Inc. (NASDAQ: OM) common
July 11, 2022
Investigations
MultiPlan Corporation
MultiPlan Corporation Misled Investors Regarding its Business Prospects Robbins LLP is investigating the officers and directors of MultiPlan Corporation (NYSE: MPLN) to determine whether they breached fiduciary duties or violated
July 11, 2022
Protect your